Targeting immune-hemodynamic coupling in early diabetic kidney disease: Mechanisms, biomarkers, and therapeutic opportunities.

Tian L, Zheng B, Pang Y, Zhao J, Wang Y, Wang M, Zhao W

Open source

DOI
10.1016/j.biopha.2026.119938
Published
2026 Sep 21
Container
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2026.119938,
  title = {Targeting immune-hemodynamic coupling in early diabetic kidney disease: Mechanisms, biomarkers, and therapeutic opportunities.},
  author = {Tian L and Zheng B and Pang Y and Zhao J and Wang Y and Wang M and Zhao W},
  year = {2026},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2026.119938},
  url = {https://doi.org/10.1016/j.biopha.2026.119938}
}

RIS

TY  - JOUR
TI  - Targeting immune-hemodynamic coupling in early diabetic kidney disease: Mechanisms, biomarkers, and therapeutic opportunities.
AU  - Tian L
AU  - Zheng B
AU  - Pang Y
AU  - Zhao J
AU  - Wang Y
AU  - Wang M
AU  - Zhao W
PY  - 2026
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2026.119938
UR  - https://doi.org/10.1016/j.biopha.2026.119938
ER  - 

APA

L, T., B, Z., Y, P., J, Z., Y, W., M, W., & W, Z. (2026). Targeting immune-hemodynamic coupling in early diabetic kidney disease: Mechanisms, biomarkers, and therapeutic opportunities.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2026.119938

Source records